These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 8287696

  • 1. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
    Chen YX, Wang SC, Zhao GN, Tang J, Zhang SX, Tang CS.
    Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
    [Abstract] [Full Text] [Related]

  • 2. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
    Bonkovsky HL, Hartle DK, Mellen BG, Kutner M, Galambos JT.
    Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
    Colantonio D, Casale R, Pasqualetti P.
    Panminerva Med; 1989 May; 31(4):166-70. PubMed ID: 2534427
    [Abstract] [Full Text] [Related]

  • 4. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [Abstract] [Full Text] [Related]

  • 5. [Human atrial natriuretic factor (hANF) in liver cirrhosis].
    Pidlich J, Müller C, Hartter E, Renner F, Klepetko W, Miholic J, Woloszczuk W.
    Acta Med Austriaca; 1987 Sep; 14(5):125-9. PubMed ID: 2964160
    [Abstract] [Full Text] [Related]

  • 6. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
    Jiménez W, Gutkowska J, Ginés P, Arroyo V, Rivera F, Rodés J.
    Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302
    [Abstract] [Full Text] [Related]

  • 7. [ANP in the cirrhotic patient. A clinical contribution].
    Parlapiano C, Labellarte A, Primi F, Cervellini P, La Torre F, Paparo SB, Baccarini S, Di Nardo A.
    Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
    [Abstract] [Full Text] [Related]

  • 8. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D, Trägner P, Wawer A, Porst H, Daniel WG, Gross P.
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 10. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide].
    Gambini G, Fioroni E, Guerra M, Moscatelli A, Valori C.
    Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847
    [Abstract] [Full Text] [Related]

  • 11. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
    Trevisani F, Colantoni A, Sica G, Gasbarrini A, D'Intino PE, De Notariis S, De Jaso R, Barbieri A, Morselli A, Gasbarrini G.
    Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
    [Abstract] [Full Text] [Related]

  • 12. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
    Burghardt W, Wernze H, Diehl KL.
    Klin Wochenschr; 1986 Jul; 64 Suppl 6():103-7. PubMed ID: 2948055
    [Abstract] [Full Text] [Related]

  • 13. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
    Kawasaki H, Uemasu J, Maeda N, Hirayama C, Kobayashi T, Sakurai H.
    Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881
    [Abstract] [Full Text] [Related]

  • 14. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W, Müller R, Diehl KL, Wernze H.
    Z Kardiol; 1988 Aug; 77 Suppl 2():104-10. PubMed ID: 2970163
    [Abstract] [Full Text] [Related]

  • 15. [Plasma endothelin level in patients with pregnancy induced hypertension and its correlation with atrial natriuretic peptide].
    Zhang SH, Yang MG, Qiu XH.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Nov; 29(11):645-7, 697. PubMed ID: 7712881
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
    Lo GH, Lam HC, Cheng JT, Lin JK, Hsu JH, Lai KH, Chiang HT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
    [Abstract] [Full Text] [Related]

  • 18. Dendroaspis natriuretic peptide in hepatic cirrhosis.
    Fábrega E, Crespo J, Rivero M, Casafont F, Castro B, García-Unzueta MT, Amado JA, Pons-Romero F.
    Am J Gastroenterol; 2001 Sep; 96(9):2724-9. PubMed ID: 11569702
    [Abstract] [Full Text] [Related]

  • 19. [Effects of autogenous reinfusion of ascitic fluid on plasma atrial natriuretic peptide and renin activity in cirrhotic patients].
    Jiang HQ, Yao XX, Liu HQ.
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):622-4, 658. PubMed ID: 1533835
    [Abstract] [Full Text] [Related]

  • 20. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL, Arendt R, Xie Y, Knorr HJ, Riedel A, Paumgartner G.
    Z Kardiol; 1988 Oct; 77 Suppl 2():99-103. PubMed ID: 2970181
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.